...
首页> 外文期刊>Drugs in R&D >Preclinical Pharmacology of Bilastine,a New Selective Histamine H_1 Receptor Antagonist Receptor Selectivity and in Vitro Antihistaminic Activity
【24h】

Preclinical Pharmacology of Bilastine,a New Selective Histamine H_1 Receptor Antagonist Receptor Selectivity and in Vitro Antihistaminic Activity

机译:Bilastine的临床前药理学,一种新型的选择性组胺H_1受体拮抗剂受体选择性和体外抗组胺活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective:This study aimed to establish the receptor selectivity and antihistamin-ic activity of bilastine,a new selective antihistamine receptor antagonist.Design and methods:In vitro experiments were conducted using a receptor binding screening panel and guinea-pig and rat tissues.Antihistaminic activity was determined using H_1 receptor binding studies and in vitro H_1 antagonism studies conducted in guinea-pig tissues and human cell lines.Receptor selectivity was established using a receptor binding screening panel and a receptor antagonism screening conducted in guinea-pig,rat and rabbit tissues.Inhibition of inflammatory mediators was determined through the Schultz-Dale reaction in sensitised guinea-pig ileum.Results:Bilastine binds to histamine H_1-receptors as indicated by its displacement of [~3H]-pyrilamine from H_1-receptors expressed in guinea-pig cerebellum and human embryonic kidney(HEK)cell lines.The studies conducted on guinea-pig smooth muscle demonstrated the capability of bilastine to antagonise H_1-receptors.Bilastine is selective for histamine H_1-receptors as shown in receptor-binding screening conducted to determine the binding capacity of bilastine to 30 different receptors.The specificity of its H_1-receptor antagonistic activity was also demonstrated in a series of in vitro experiments conducted on guinea-pig and rat tissues.The results of these studies confirmed the lack of significant antagonism against serotonin,bradykinin,leukotriene D_4,calcium,muscarinic M_3-receptors,alpha_1-adrenoceptors,beta_2-adrenoceptors,and H_2- and H_3-receptors.The results of the in vitro Schultz-Dale reaction demonstrated that bilastine also has anti-inflammatory activity.Conclusions:These preclinical studies provide evidence that bilastine has H_1-antihistamine activity,with high specificity for H_1-receptors,and poor or no affinity for other receptors.Bilastine has also been shown to have anti-inflammatory properties.
机译:目的:本研究旨在建立一种新型的选择性抗组胺受体拮抗剂比拉汀的受体选择性和抗组胺活性。设计与方法:使用受体结合筛选板,豚鼠和大鼠组织进行体外实验。通过在豚鼠组织和人细胞系中进行的H_1受体结合研究和体外H_1拮抗作用研究确定受体的选择性。使用受体结合筛选小组以及在豚鼠,大鼠和兔子组织中进行的受体拮抗作用筛选来建立受体选择性。通过Schultz-Dale反应确定致敏的豚鼠回肠中炎性介质的抑制作用。结果:通过从豚鼠小脑中表达的H〜[3H]-吡胺中置换出[〜3H]-吡胺,表明了双氨嘧啶与组胺H_1-受体的结合。和人类胚胎肾(HEK)细胞系。对豚鼠平滑肌的研究证明了其功能比拉汀对H_1受体的拮抗作用,如对受体结合筛选确定比拉汀对30种不同受体的结合能力所显示的那样,比拉汀对组胺H_1受体具有选择性,还证明了其对H_1受体的拮抗活性的特异性。在豚鼠和大鼠组织上进行的一系列体外实验。这些研究结果证实,它们对5-羟色胺,缓激肽,白三烯D_4,钙,毒蕈碱M_3-受体,α_1-肾上腺素受体,β_2-肾上腺素受体和它们没有明显的拮抗作用。 H_2-和H_3-受体。体外Schultz-Dale反应的结果表明,比拉汀还具有抗炎活性。结论:这些临床前研究提供了证据,证明比拉汀具有H_1-抗组胺活性,对H_1-受体具有高特异性,并且对其他受体的亲和力很弱或没有亲和力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号